According to recent research conducted by Amylin Pharmaceuticals and Eli Lilly, and reported in Diabetes Care, type 2 diabetes significantly increases the risk of developing acute pancreatitis and biliary disease.
The research, conducted in San Diego, California, showed that those with type 2 diabetes faced a three times greater risk of the former, and a two times greater risk of the latter condition when compared to people without diabetes .
Dr. Bloomgre, lead author was reported as commenting: “The increased risk of pancreatitis for patients with type 2 diabetes…combined with the increasing prevalence of diabetes and the associated risk factors, may be contributing to a meaningful increase in the incidence of acute pancreatitis in the US.”
To reach the conclusion the researchers studied a database of over a million adults.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…